LAUREN RILEY: Open Payments
NPI 1467794685 · FAIR HAVEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 14 payments from 8 companies in 2025. Trend: 2023 $968 · 2024 $761 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $64 |
| Incyte Corporation | 2 | $34 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| GENZYME CORPORATION | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Organon LLC | 2 | $5 |
Products named: NEMLUVIO, OPZELURA, Cabtreo, COSENTYX, DUPIXENT, OTEZLA, SKYRIZI, VTAMA.
Industry payments across NJ — which companies pay providers there.
